Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants

Insights

Early peanut introduction in infants, rather than delayed introduction, may offer benefits for allergy prevention. This interim guidance reflects a consensus among leading allergy and pediatric organizations worldwide.

Area of Science:

  • Pediatric Allergy and Immunology
  • Infant Nutrition
  • Food Allergy Prevention

Background:

  • Emerging evidence suggests a shift in recommendations for infant feeding practices.
  • Existing guidelines are being re-evaluated based on new research findings.
  • The focus is on the timing of introducing allergenic foods, specifically peanuts.

Purpose of the Study:

  • To highlight emerging evidence on early peanut introduction in infants.
  • To provide interim guidance on complementary feeding practices.
  • To inform healthcare professionals and parents about potential allergy prevention strategies.

Main Methods:

  • Consensus statement based on emerging scientific evidence.
  • Review of current understanding of infant immune system development and allergen exposure.
  • Collaboration among leading allergy and pediatric organizations worldwide.

Main Results:

  • Emerging evidence supports earlier, rather than delayed, introduction of peanuts.
  • Early introduction during complementary feeding may offer benefits in allergy prevention.
  • This communication serves as interim guidance pending formal guidelines.

Conclusions:

  • Early peanut introduction is a key area of focus for infant allergy prevention.
  • Healthcare providers should consider current evidence when advising on infant diets.
  • Formal guidelines on complementary feeding and allergy risk are forthcoming.

Related Concept Videos

Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
1.6K
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
188
Allergic Reactions02:06

Allergic Reactions

Overview
33.9K
Hypersensitivity Reactions: Delayed Hypersensitivity Reactions01:29

Hypersensitivity Reactions: Delayed Hypersensitivity Reactions

Delayed-Type Hypersensitivity (DTH), or Type IV hypersensitivity, is a cell-mediated immune response. It occurs when T cells, rather than antibodies, mediate a reaction to specific antigens. It is characterized by a delayed onset (1-2 days) and involves the recruitment of macrophages to the inflammation site.The initiation of a DTH response begins with the sensitization of T cells. During this phase, which lasts at least 1-2 weeks, antigen-specific T cells are activated, clonally expanded, and...
225
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K